US regulator cautions against using chloroquine outside of hospitals or clinical trials

Severin Schwan unapologetic for outspoken criticism of state responses to coronavirus

Start every week on the front foot with a preview of what’s on the global agenda

Scientists co-operate on search for Covid-19 origins despite charges Beijing is withholding data

Funding bodies face a choice between established manufacturers and biotech upstarts

Boss of clothing retailer deserves a premium; Astra’s eyes on big prize

US-run trial of Gilead coronavirus therapy demonstrates ‘significant positive effect’

Gilead’s potential coronavirus treatment stirs investor hopes but evidence on effectiveness is mixed

Partnership that would prioritise UK could produce 100m doses by year-end if treatment is effective

Research paper published in journal Nature identifies number of alternative treatments

First country to get a vaccine could have an economic as well as a health advantage

Biotech group’s shares have soared this year on hopes drug could be used to treat coronavirus

US-led trial shows positive results in hastening recovery time for coronavirus patients

Investors have bet on Gilead’s remdesivir as solution to coronavirus crisis

Sum far exceeds $8bn fundraising target at upcoming EU-led donors’ conference

Nation’s pharma industry has matured but is still a lot better at incremental innovation than major breakthroughs

Industry highlights bottlenecks in access to materials that are a possible Covid-19 treatment

As researchers race to develop a coronavirus vaccine, we look at efforts to ensure that the world’s poor are not left behind — and ask whether the pandemic will jolt policymakers into confronting the looming threat from antimicrobial resistance

The world needs to act now to avert the threat from antimicrobial resistance

Pharma and its critics agree government has a big role to play in ensuring fair access to Covid-19 remedies

Federal Trade Commission votes 3-2 to approve tie-up between makers of Botox and Humira

The wide variety of Covid-19 symptoms seen by doctors is confounding the scientific community

Fund managers and energy-hungry tech companies bankroll ‘solar-plus-storage’ projects

Schemes to look at cutting emissions in sectors such as transport in push to meet 2050 ‘net zero’ target

California utility discloses $5bn pre-tax charge tied to claims

The president has turned his populist fire on big business, but is he attacking corporate greed or political opponents?

State-backed utility under pressure as it plans to invest in new coal mines

Shares in Peabody Energy and Arch Coal fall sharply after regulatory action

Group says 230 jobs will be lost at Selby site at it looks to beat 2025 fossil fuel deadline

American producers are coming under pressure on several fronts

Policy reversal follows Cameron vow to rid UK of ‘unsightly’ structures

Demand for classically defensive stocks rises as viral outbreak worsens

As Beijing connects the region, the Philippines weighs ‘shutdown’ risk

Climate campaigners say measures lack ambition to tackle crisis

One of the first large acquisitions to be agreed since coronavirus pandemic rocked global markets

Energy, water and other utility groups keep services going despite lockdowns and cuts

Decline leads to a drop in wholesale prices as businesses close

Loan scheme worth up to £100m a month would allow suppliers to assist struggling customers

First signs of severity of coronavirus pandemic on UK energy sector 

A boom in projects across the Permian Basin comes amid coronavirus fears and a global oil price war 

Supplier says sector should be ‘back of the queue’ for additional government support

Shutdowns likely to shift energy use from fossil fuels towards wind and solar

If lenders maintain support, the company’s balance sheet may not need an urgent fix

Suffolk residents cry foul as French group seeks to continue process despite lockdown  

Chipmaker likely to be interested in app’s traffic data rather than its customers

Potential cost cuts should not be used as justification for a UK telecoms tie-up

British and American consumers are unlikely to ‘spend, spend, spend’ after the lockdowns

Customers and investors may appear immune to staff complaints but regulators have not lost interest

Well-capitalised businesses will have an increased advantage for the next few years